Skip to search.
 FTSE 100 Up 0.33%

More On ADA.F

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

  • Headlines
  • Company Events

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

Financials

Achillion Pharmaceuticals, Inc. (ADA.F)

-Frankfurt
4.10 Up 0.22(5.62%) 9 Dec 14:35
Prev Close:3.88
Open:4.10
Bid:4.05 x 43600
Ask:4.13 x 42000
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:4.10 - 4.10
52wk Range:3.74 - 9.75
Volume:86
Avg Vol (3m):114
Market Cap:559.71m
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in EUR.

Headlines

  • No Headlines available for ADA.F at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.77
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes small molecule drug therapies for infectious diseases and immune system disorders in the United States and internationally. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback